Mirae Asset Global Investments Co., Ltd. Vanda Pharmaceuticals Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $20 Billion
- Q2 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,738 shares of VNDA stock, worth $7,821. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,738
Previous 27,868
93.76%
Holding current value
$7,821
Previous $114,000
92.11%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding VNDA
# of Institutions
156Shares Held
45.1MCall Options Held
136KPut Options Held
220K-
Black Rock Inc. New York, NY8.14MShares$36.6 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.11MShares$18.5 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.43MShares$15.4 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA2.15MShares$9.69 Million1.49% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.01MShares$9.06 Million0.0% of portfolio
About Vanda Pharmaceuticals Inc.
- Ticker VNDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,561,500
- Market Cap $255M
- Description
- Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...